menu
    • menu

    Company profile for Stelis Biopharma

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Stelis Biopharma Private Limited ( Stelis) is a vertically integrated biopharmaceutical company with R&D, process scale up and end –to- end manufacturing capabilities from drug substance to finished drug products in all injectable formats. Stelis has a state of the art research facility in Bengaluru along with a soon-to-be commissioned 200,000 square feet integrated bio-manufacturing facility catering to biologic APIs and in...
    Stelis Biopharma Private Limited ( Stelis) is a vertically integrated biopharmaceutical company with R&D, process scale up and end –to- end manufacturing capabilities from drug substance to finished drug products in all injectable formats. Stelis has a state of the art research facility in Bengaluru along with a soon-to-be commissioned 200,000 square feet integrated bio-manufacturing facility catering to biologic APIs and injectables conforming to international standards.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Stelis Biopharmaindia-flag Flag
    Country
    Country
    India
    Address
    Address
    '293, Jigani Link Road, Bommasandra, Anekal Taluk Bangalore – 560 105 ,'
    Telephone
    Telephone
    91 80 6784 0444
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://stelis.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    OneSource in talks to raise Rs 1,670 crore in pre-listing round
    OneSource in talks to raise Rs 1,670 crore in pre-listing round

    26 Sep 2024

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/onesource-in-talks-to-raise-rs-1670-crore-in-pre-listing-round/articleshow/113677721.cms

    ECONOMICTIMES
    26 Sep 2024
    Share Share
    Stelis Biopharma updates on receipt of consideration from Syngene
    Stelis Biopharma updates on receipt of consideration from Syngene

    25 Dec 2023

    // INDIAN PHARMA POST

    https://www.indianpharmapost.com/news/stelis-biopharma-updates-on-receipt-of-consideration-from-syngene-15058

    INDIAN PHARMA POST
    25 Dec 2023
    Share Share
    Syngene concludes acquisition of biologics manufacturing facility from Stelis
    Syngene concludes acquisition of biologics manufacturing facility from Stelis

    03 Dec 2023

    // INDIAN PHARMA POST

    https://www.indianpharmapost.com/news/syngene-concludes-acquisition-of-biologics-manufacturing-facility-from-stelis-biopharma-14961

    INDIAN PHARMA POST
    03 Dec 2023
    Share Share
    Akston Biosciences Ends Vaccine Partnership with Stelis
    Akston Biosciences Ends Vaccine Partnership with Stelis

    07 Mar 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230306005704/en

    BUSINESSWIRE
    07 Mar 2023
    Share Share
    Stelis Biopharma receives establishment inspection report from USFDA
    Stelis Biopharma receives establishment inspection report from USFDA

    18 Jan 2023

    // ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/stelis-biopharma-receives-establishment-inspection-report-from-usfda/articleshow/97083675.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

    ECONOMIC TIMES
    18 Jan 2023
    Share Share
    Stelis Biopharma requests PM Modi for procurement of jabs
    Stelis Biopharma requests PM Modi for procurement of jabs

    14 May 2022

    // ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/unable-to-sell-sputnik-light-stock-stelis-biopharma-requests-pm-modi-for-procurement-of-jabs/articleshow/91560927.cms

    ECONOMIC TIMES
    14 May 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search